Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianjun Yu

Showing results (291-300 of 325) with videos related to

Pageof 33
Sort By:
Journal of Cancer|April 4, 2017
Upregulated long non-coding RNA LINC00152 expression is associated with progression and poor prognosis of tongue squamous cell carcinomaJianjun Yu, Yan Liu, Can Guo, et al.
Breast Cancer Research and Treatment|September 2, 2021
Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and ChinaXiaoran Liu, Andrew A Davis, Feng Xie, et al.
The New England Journal of Medicine|September 24, 2005
Autoantibody signatures in prostate cancerXiaoju Wang, Jianjun Yu, Arun Sreekumar, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 2, 2021
Single-cell RNA sequencing in cancer researchYijie Zhang, Dan Wang, Miao Peng, et al.
Cancer Cell|November 13, 2007
Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancerJindan Yu, Qi Cao, Rohit Mehra, et al.
Cancer Cell|November 16, 2005
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progressionSooryanarayana Varambally, Jianjun Yu, Bharathi Laxman, et al.
Nature Communications|July 7, 2025
Low-noise frequency synthesis and terahertz wireless communication driven by compact turnkey Kerr combsKunpeng Jia, Yuancheng Cai, Xinwei Yi, et al.
Atherosclerosis|February 25, 2025
Efficacy and safety of ongericimab in Chinese patients with heterozygous familial hypercholesterolemia: A randomized, double-blind, placebo-controlled phase 3 trialJie Lin, Yuan Ji, Gaopin Wang, et al.
Cancer Research|September 7, 2007
Integrative analysis of genomic aberrations associated with prostate cancer progressionJung H Kim, Saravana M Dhanasekaran, Rohit Mehra, et al.
Neoplasia (New York, N.Y.)|October 28, 2008
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancerSooryanarayana Varambally, Bharathi Laxman, Rohit Mehra, et al.
Pageof 33

Showing results (291-300 of 325) with videos related to

Sort By:
Pageof 33
Journal of Cancer|April 4, 2017
Upregulated long non-coding RNA LINC00152 expression is associated with progression and poor prognosis of tongue squamous cell carcinomaJianjun Yu, Yan Liu, Can Guo, et al.
Breast Cancer Research and Treatment|September 2, 2021
Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and ChinaXiaoran Liu, Andrew A Davis, Feng Xie, et al.
The New England Journal of Medicine|September 24, 2005
Autoantibody signatures in prostate cancerXiaoju Wang, Jianjun Yu, Arun Sreekumar, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 2, 2021
Single-cell RNA sequencing in cancer researchYijie Zhang, Dan Wang, Miao Peng, et al.
Cancer Cell|November 13, 2007
Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancerJindan Yu, Qi Cao, Rohit Mehra, et al.
Cancer Cell|November 16, 2005
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progressionSooryanarayana Varambally, Jianjun Yu, Bharathi Laxman, et al.
Nature Communications|July 7, 2025
Low-noise frequency synthesis and terahertz wireless communication driven by compact turnkey Kerr combsKunpeng Jia, Yuancheng Cai, Xinwei Yi, et al.
Atherosclerosis|February 25, 2025
Efficacy and safety of ongericimab in Chinese patients with heterozygous familial hypercholesterolemia: A randomized, double-blind, placebo-controlled phase 3 trialJie Lin, Yuan Ji, Gaopin Wang, et al.
Cancer Research|September 7, 2007
Integrative analysis of genomic aberrations associated with prostate cancer progressionJung H Kim, Saravana M Dhanasekaran, Rohit Mehra, et al.
Neoplasia (New York, N.Y.)|October 28, 2008
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancerSooryanarayana Varambally, Bharathi Laxman, Rohit Mehra, et al.
Pageof 33